Cumberland Pharmaceuticals (CPIX) Share-based Compensation (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Share-based Compensation of $106842.0 for Q1 2026, down 47.15% sequentially from $202151.0 in Q4 2025, and up 43.97% YoY from $74212.0 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Share-based Compensation (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Share-based Compensation for 17 years, with the latest figure at $106842.0 in Q1 2026.
- Quarterly Share-based Compensation rose 43.97% year-over-year to $106842.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $470941.0 (up 281.34% YoY) and the FY2025 annual result came in at $438311.0, up 242.33% from the prior year.
- Share-based Compensation slipped to $106842.0 in Q1 2026 per CPIX's latest filing, from $202151.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $4.3 million in Q4 2022 and troughed at -$99044.0 in Q4 2024.
- A 5-year average of $377796.3 and a median of $83112.0 in 2023 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 925.86% in 2022, down 114.46% in 2022.
- Over 5 years, Share-based Compensation stood at $4.3 million in 2022, then slumped by 79.22% to $887221.0 in 2023, then plunged by 111.16% to -$99044.0 in 2024, then jumped by 304.1% to $202151.0 in 2025, then sank by 47.15% to $106842.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $106842.0, $202151.0, and $81262.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.08 Mn | 113.22 Mn | - | 77,866.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77,866.00 |
| Jun 30, 2026 | 77,866.00 |
| Mar 31, 2026 | 106,842.00 |
| Mar 31, 2026 | 106,842.00 |
| Dec 31, 2025 | 202,151.00 |
| Dec 31, 2025 | 202,151.00 |
| Sep 30, 2025 | 81,262.00 |
| Sep 30, 2025 | 81,262.00 |
| Jun 30, 2025 | 80,686.00 |
| Jun 30, 2025 | 80,686.00 |
| Mar 31, 2025 | 74,212.00 |
| Mar 31, 2025 | 74,212.00 |
| Dec 31, 2024 | -99,044.00 |
| Dec 31, 2024 | -99,044.00 |
| Sep 30, 2024 | 76,371.00 |
| Sep 30, 2024 | 76,371.00 |
| Jun 30, 2024 | 71,958.00 |
| Jun 30, 2024 | 71,958.00 |
| Mar 31, 2024 | 78,754.00 |
| Mar 31, 2024 | 78,754.00 |